Wagner Wealth Management (South Carolina)’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-160
Closed -$5K 447
2022
Q3
$5K Buy
+160
New +$6.06K ﹤0.01% 520
2022
Q1
Sell
-1,384
Closed -$76K 399
2021
Q4
$76K Buy
1,384
+160
+13% +$8.32K 0.06% 202
2021
Q3
$65K Hold
1,224
0.05% 208
2021
Q2
$61K Buy
+1,224
New +$58.8K 0.04% 232
2018
Q3
$43K Buy
+859
New +$43.6K 0.03% 264
2017
Q4
Hold
0
290

Other funds holding GSK

Wagner Wealth Management (South Carolina)'s GSK Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of GSK (GSK) in Q4 2022, closing a stake of 160 shares — an estimated $5K sold.

Wagner Wealth Management (South Carolina) first reported a position in GSK in Q3 2018 and held it in 5 quarters. The position peaked at $76K in Q4 2021. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 160 GSK shares in Q4 2022, an estimated $5K.
  • Wagner Wealth Management (South Carolina) first reported a position in GSK in Q3 2018 and held it in 5 quarters.
  • Wagner Wealth Management (South Carolina)'s GSK position peaked at $76K in Q4 2021.
  • 813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.